Abstract. A fluorescent DNA probe (LEIS.P1) specific for a conserved region of the small-subunit ribosomal RNA gene of Leishmania and a pair of flanking primers (LEIS.U1 and LEIS.L1) were designed for use in a fluorogenic polymerase chain reaction. Optimal assay conditions with zero background were established to detect low levels of Leishmania from clinical samples. By use of this assay, we amplified DNA from 27 strains of cultured Leishmania (both Old and New World strains) and selectively amplified Leishmania DNA from 12 paraffin-embedded human biopsy samples and 3 fresh human skin biopsy specimens. For the fresh human tissue biopsies, the turnaround time from biopsy to test result was Ͻ 24 hr. No amplification was detected in negative control samples (including the kinetoplastid protozoa Trypanosoma rangelli and Crithidia fasiculata). This assay provides a specific and rapid diagnostic modality to detect infection with Leishmania.
INTRODUCTION
Leishmaniasis is a disease with a wide spectrum of clinical presentations, ranging from self-healing cutaneous lesions to progressive, and potentially fatal, visceral disease. Diagnosis relies predominantly on tissue biopsy, with identification of the amastigote form via histopathology or growth of the promastigote stage in culture. Both of these methods are relatively time-consuming and require considerable expertise. Polymerase chain reaction (PCR)-based methods for detecting Leishmania DNA have been increasingly reported and are attractive for their potential sensitivity, specificity, and timeliness. Ribosomal RNA (rRNA), [1] [2] [3] the mini-exon gene, 4, 5 repetitive nuclear DNA sequences, 6, 7 and kinetoplast DNA 8, 9 have all been reported as potential targets for PCR amplification. Fluorogenic PCR is a real-time PCR wherein 2 fluorescent dyes, a reporter and a quencher, are attached to the 5Ј and 3Ј ends of a probe. When the probe is intact, the proximity of the quencher greatly reduces the fluorescence emitted by the reporter dye. In the presence of an appropriate target, the probe anneals downstream from one of the primer sites and is cleaved by the 5Ј nuclease activity of Taq DNA polymerase as this primer is extended. This cleavage of the probe separates the reporter dye from quencher dye, resulting in an increase in the reporter dye signal. Cleavage removes the probe from the target strand, allowing primer extension to continue to the end of the template strand. Additional reporter dye molecules are cleaved from their respective probes with each cycle, resulting in an increase in fluorescence intensity proportional to the amount of amplicon produced. 10, 11 There are several advantages to this technology over standard PCR methods. First, nonspecific amplification due to mispriming or primer-dimer artifact does not generate signal. Second, without gels or hybridization assays to perform, high sample throughput is possible. Finally, by use of reaction tubes that remain closed during the PCR amplification and detection process, there is a reduced chance of contamination.
In this study, we describe the use of fluorogenic PCR for the detection of Leishmania. Although several targets for amplification that used PCR technology were considered, previous studies had demonstrated that a probe-target mismatch of a single base may prevent annealing. 12 Because we were interested in developing an assay that would detect all species of Leishmania, a segment of the small-subunit (SSU) rRNA gene was chosen as the target because it is conserved among all Leishmania. 1 
MATERIALS AND METHODS
Extraction of Leishmania DNA. The Leishmania DNA used in this study was either extracted from cultured promastigotes or extracted from tissue biopsies obtained from patients diagnosed with leishmaniasis. For the promastigotes, the isolates were provided by the Leishmania Diagnostics Laboratory, Walter Reed Institute of Research, Washington, DC. Promastigotes used in this assay were cultured at 24ЊC in Schneider's Drosophila medium (Gibco BRL, Grand Island, NY) containing 20% fetal calf serum, [13] [14] [15] and identified by isoenzyme analysis. 16, 17 Parasites were harvested at a density of 2 ϫ 10 7 parasites/mL, pelleted at 2,000 ϫ g for 8 min at 4ЊC, washed 3 times in phosphate-buffered balanced salt solution (PBSS) pH 7.4, and then resuspended in 500 L PBSS. The DNA was purified by column chromatography (QIAamp Blood and Blood Products Kit, Qiagen, Chatsworth, CA) following the manufacturer's instructions. For DNA extracted from tissue samples, 12 paraffinembedded tissue blocks from patients evaluated from 1994-1997 and proven by culture to have leishmaniasis were obtained from the Walter Reed Army Medical Center. Five 5-m thick sections were cut from each block and combined for DNA extraction. New blades were used for each block, and the block holder and knife were cleaned with 70% alcohol and bleach in between each block to avoid contamination. 18 Removal of paraffin and DNA purification (by column chromatography) were performed according to the manufacturer's instructions (QIAamp Tissue Kit; Qiagen).
To evaluate this assay on fresh human tissue prospectively, 3-mm punch biopsies of skin lesions were obtained from 3 patients undergoing evaluation for suspected cutaneous leishmaniasis at the Walter Reed Army Medical Center, and DNA extraction was performed with the QIAamp Tissue Kit. Individual cutaneous tissue biopsies were processed and cul-tured, and each demonstrated promastigote growth. [13] [14] [15] Isoenzyme analysis of these cultured promastigotes revealed Leishmania Leishmania major in all 3 cases. The patients had given informed consent and were enrolled in a protocol comparing various Leishmania diagnostic modalities that were approved by the Walter Reed Army Medical Center, Washington, DC, institutional review board.
For negative controls, DNA was extracted from 39 tissue blocks from patients diagnosed with a variety of other nonleishmanial pathologies (including 2 cardiac samples from patients with Chagas disease), as well as DNA from cultures of the kinetoplastid protozoa, Trypanosoma rangelli and Crithidia fasiculata (American Type Culture Collection [ATCC], Manassas, VA).
Polymerase chain reaction assay. The fluorogenic probe (LEIS.P1) and its flanking primers (LEIS.U1 and LEIS.L1) were designed specifically for use in this assay. LEIS.P1 is an oligonucleotide sequence with a 5Ј reporter dye (FAM, 6-carboxy-fluorescein) and a downstream 3Ј quencher dye (TAMRA, 6-carboxy-tetramethyl-rhodamine). Both labeled and nonlabeled oligonucleotides were synthesized by the Oligo-factory (PE Biosystems, Foster City, CA).
The PCR reactions were conducted in a 50-L volume containing 2.0 L DNA template, 1ϫ Taqman buffer (PE Biosystem), 0.2 mM deoxynucleotide triphosphate (dNTPs), 2 mM MgCl 2 , 20 nM LEIS.P1, 200 nM LEIS.U1, 200 nM LEIS.L1, and 1.25 U AmpliTaq Gold DNA polymerase (PE Biosystem). Gene detection system 7700 and sequence detection system software version 1.6.3 (PE Biosystem) were employed for PCR cycling reaction, real-time data collection, and analysis. The PCR mixtures were preincubated at 50ЊC for 2 min, then 95ЊC for 10 min, followed by 40 cycles of 2-step incubations at 95ЊC for 15 sec and 60ЊC for 1 min. All reactions were run in duplicate, and the threshold cycle (C T ) was reported as the mean value. The threshold cycle is defined as the cycle number where the sequence detection application software detects the increase of fluorescence associated with the exponential amplification of PCR product.
Design and synthesis of PCR primers and fluorogenic hybridization probe. The fluorogenic probe (LEIS.P1) and its flanking primers (LEIS.U1 and LEIS.L1) were designed on the basis of an alignment of the Leishmania SSU rRNA genes as published in GenBank (Figure 1) .
, and 3 members of the L. Viannia complex (M80292, M81416, and M81421) were aligned by the CLUSTAL program in the Lasergene software package (DNAStar, Madison, WI), and areas that demonstrated homology were examined. Because Van Eys and others 1 had previously published information that primer R223 demonstrated specificity for the genus Leishmania, we designed the LEIS.P1 probe with respect to this area of the rRNA gene. Presumptive sequences were compared with a DNA sequence data base (BLAST, version 2.0, National Center for Biotechnology and Information, Bethesda, MD). Except for a reported sequence of Endotrypanum monterogeii SSU rRNA gene, the sequence chosen for probe LEIS.P1 (5Ј-CGGTTCGGTGTGTGGCGCC-3Ј) demonstrates homology only with the Leishmania SSU rRNA gene. PRIMER EX-PRESS software (PE Biosystem) was then used to design appropriate flanking primers for the LEIS.P1 probe. The oligonucleotide sequences of the primers are LEIS.U1 (5Ј-AAGTGCTTTCCCATCGCAACT-3Ј) and LEIS.L1 (5Ј-GA-CGCACTAAACCCCTCCAA-3Ј).
A 
RESULTS
Preliminary observations. Parasites from L. L. mexicana (WR 2313) were harvested at a density of 2 ϫ 10 7 parasites/ mL, and the DNA was extracted and resuspended in 50 L to a concentration of 0.04 g/L. Eleven 5-fold dilutions were used as DNA templates in the fluorogenic PCR assay. Figure 2 demonstrates the typical sigmoid plots representing specific PCR product accumulation in fluorescence (⌬Rn) as amplification progressed (cycle number). Larger initial DNA concentrations required fewer amplification cycles (smaller C t ) to reach detectable fluorescence level, whereas serial dilutions resulted in a shift to the right (higher C t value) of each curve. The furthest curve to the right (with a C t of 40) represents nontemplate (water) controls. These results demonstrate that this assay can detect the Leishmania rRNA gene over 11 serial 5-fold dilutions and can discriminate this target sequence from background levels (nontemplate controls).
Detection of the Leishmania rRNA gene in cultured promastigotes. All 27 strains of Leishmania tested positive with a threshold cycle (C t ) of Ͻ 40 (Table 1 ). The segment of rRNA gene chosen for amplification appears to be conserved in the Leishmania genus because multiple strains from New and Old World Leishmania were amplified with this assay. Importantly, this segment of DNA appears to be specific for Leishmania, as the related Trypanosomes T. rangelli and C. fasiculata were not amplified. Table 1 ). The C t values tended to be higher for clinical samples than for cultured promastigotes and may reflect the lower concentration of rRNA in biopsy samples (which required more cycles to amplify the target to detectable levels).
Detection of the
Detection of the Leishmania rRNA gene in negative controls. All negative controls (including DNA from the nonleishmanial kinetoplastid controls T. rangelli and C. fasiculata) were negative in this assay, with a C t of 40 (indicating no PCR amplification) ( Table 2) . These results demonstrate the specificity of this assay and confirm that these primers and probe selectively amplify the Leishmania rRNA gene. 
DISCUSSION
We have developed what is to our knowledge the first use of fluorogenic PCR for the diagnosis of leishmaniasis. Molecular diagnostic assays for leishmaniasis are potentially advantageous because current diagnostic modalities (culture and histopathology) require expertise and are relatively timeconsuming. In addition, traditional diagnostic techniques can be insensitive in some forms of leishmaniasis (i.e., mucosal disease), although detection by PCR has been reported. 19 For example, one study recently published a diagnostic sensitivity of 62% for conventional techniques versus 94% for PCR in detecting tegumentary leishmaniasis (in patients with mucosal disease, the diagnostic yield with conventional techniques was 17% versus 71% with PCR). 19 Polymerase chain reaction is not without drawbacks: requirements for technical training, the need for multistep assays (PCR, followed by electrophoresis, then a confirmatory hybridization assay), and the potential for contamination are well-known ones. Fluorogenic PCR, with its near-complete automation, appears to have eliminated many of these shortfalls and could probably serve as a field-based diagnostic assay.
Our results demonstrate that by targeting a segment of the Leishmania 16S rRNA gene for amplification, this assay can provide identify at the genus level all strains tested and is able to distinguish Leishmania from the closely related Trypanosomes Trypanosoma rangelli and Crithidia fasiculata. Identification at the species level still relies most commonly on isoenzyme analysis of cultured promastigotes, although species identification has been shown by use of DNA-based 6, [20] [21] [22] [23] [24] The methods required to perform species-level identification were not compatible with our goal of developing a rapid diagnostic assay, and we therefore concentrated our efforts on genus-level identification. Future studies will focus on designing probes for rapid species-level identification.
Because the purpose of this study was to design a diagnostic assay for the detection of Leishmania DNA in patients with leishmaniasis, paraffin-embedded and fresh human tissue samples were tested. We were lucky because 3 patients with suspected leishmaniasis presented for evaluation during the course of this study, and we were therefore able to prospectively compare this assay with other diagnostic modalities in real time. All 12 paraffin-embedded samples were positive for leishmaniasis by PCR, as were the 3 fresh tissue samples. The turnaround time, from performance of the biopsy to result of the PCR, was under 24 hr. In comparison, the time for a histology sample to be processed at our institution is 3 days, and the mean time for a culture to become positive is 7 days. Unfortunately, the limited number of fresh biopsy samples prohibited us from defining the sensitivity and specificity of this fluorogenic assay in detecting Leishmania in clinical samples. Because histologic review of tissue specimens for the presence of Leishmania amastigotes requires considerable expertise, and because culture of the parasite is not readily available in most laboratories, the development of a rapid and reproducible molecular assay would be of benefit. Results from the current study suggest that the assay described in the report has great potential as an adjunct to current diagnostic methods. 
